TRA is on the ropes possible TKO

Anonymous

Guest
Increased risk of bleeding in stroke patients = just another anti-platelet agent and potentially inferior to ticagrelor. This makes triple anti-platelet therapy even more unlikely than before, highly likely this product won't amount to much = really bad news for us.
 






Increased risk of bleeding in stroke patients = just another anti-platelet agent and potentially inferior to ticagrelor. This makes triple anti-platelet therapy even more unlikely than before, highly likely this product won't amount to much = really bad news for us.

I wouldn't say "TKO". I would say, KO in the first 10 seconds....